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Since  the  early  classic  work  on  murine  lymphocyte cell  surface  differentiation 
antigens (1), immunological analysis of the cell surface has been a powerful tool with 
which to distinguish  and separate different classes of functional cell types  (2).  The 
development of the monoclonal antibody technique  (3)  has dramatically increased 
the ease with which cell surface antigenic determinants restricted to particular types 
of differentiated cells can be identified. If the objective in identifying differentiation 
antigens is solely to provide the means of discriminating one kind of cell from another, 
then the molecular basis of the antigenic difference between cells is of little practical 
consequence. If, however, one wishes to investigate the potential functional signifi- 
cance  of a  particular  antigenic  determinant  restricted  to  surface  structures  of a 
particular  cell  type,  then  the  structural  basis  of the  antigenic  determinant  is  of 
considerable  importance.  One  striking  example  of  the  structural  and  antigenic 
complexity  of cell  surface  glycoproteins  is  the  family  of high  molecular  weight 
leukocyte differentiation antigens found in several species, including man, referred to 
as  T200  or  leukocyte common  antigen  (4-9).  Monoclonal  antibodies  have  been 
described that react with all the structural variants ofT200 glycoprotein (4, 6, 8), and 
distinguish  hematopoietic  cells  from  other  differentiated  cell  types,  while  other 
monoclonal  antibodies  have  been  obtained  that  react  only with  the  form  of the 
glycoprotein found on bone marrow derived B cells and their precursors (10, 11), thus 
discriminating these cells from other classes of hematopoietic cells. 
Recently a cell surface antigen known as Mac-1 has been identified by means of a 
monoclonal antibody designated M 1/70 (12,  13). The antigenic determinant defined 
by the  MI/70  monoclonal  antibody is  restricted  in  distribution  to  the  surface of 
macrophages and it was inferred that the antibody recognized a molecule specific to 
phagocytes  (13).  Here we show that  the  glycoprotein bearing the  Mac-1  antigenic 
determinant belongs to a family of antigenically and structurally related glycoproteins 
analogous to the T200 glycoprotein family. Variants of these glycoproteins are found 
on a  much wider variety of hematopoietic cells than mononuclear phagocytes. This 
finding  has  implications  for  the  biological  function  of Mac-1  and  these  related 
structures. 
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Materials  and Methods 
Cell Lines.  The cell lines used in these studies were the murine T  cell lymphoma, BW5147 
(14), and the inducible murine myeloid cell line, M 1 (15). Cells were maintained in Dulbecco's 
modified  Eagle's medium  supplemented  with  10%  horse  serum.  M1  cells  were  induced  to 
differentiate along the macrophage lineage by exposure to 5 X 10  -6 M dexamethasone (16) for 
2-5 d. 
Immunological Reagents and Procedures.  The derivation and properties of monoclonal antibodies 
M1/70,  defining Mac-l, and I3/2, defining an antigenic determinant  of murine T200 glyco- 
protein, have been described previously (4,  12,  13). Monoclonal antibodies I21/7 and C71/16 
are rat IgG monoclonal antibodies derived from hybridomas obtained by standard procedures 
(3, 4) from fusions of Lewis rat spleen cells with either MPC. 11.TG. 1.7.Oua  R myeloma cells, in 
the ease of I21/7, or S194/5.XX0.BU.1  myeloma cells, in the case ofC71/16. The immunogen 
was whole  BW5147 cells  for I21/7  monoclonal antibody  and  cell  membrane  glycoproteins 
derived  from BW5147 cells  for C71/16  monoclonal antibody.  Hybridomas producing these 
monoclonal antibodies have been cloned and are stable. 
Immunoprecipitation studies using ascitic fluid from tumor-bearing mice as the source of 
I21/7  and  C71/16  monoclonal  antibodies  and  culture  supernates  as  the  source  of MI/70 
antibody were carried out as described previously (17). A goat-anti-rat IgG serum was used as 
a  second stage  reagent,  and  antibody-antigen  complexes were  isolated  from cell  lysates by 
adsorption to fixed Staphylococcus aureus. Fluorescence-activated cell analysis was carried out on 
a Los Alamos type cell sorter (model BCS-176 biological cell sorter, Research Developments, 
Los Alamos, N. M.)  using an argon laser at 488 ~ essentially as described previously (18). The 
cell sorter is equipped with a three-decade logarithmic amplifier for fluorescence analysis, and 
relative fluorescence of stained cells was estimated  from a  standard  curve constructed using 
fluorescent beads of known brightness. 
Biochemical  Procedures.  Cells  were labeled by the glucose oxidase modification of the lacto- 
peroxidase technique (17, 19). Immunoprecipitates were analyzed on 7.5% polyacrylamide gels 
using a discontinuous buffer system (20). Autoradiography was performed using intensifying 
screens  (21).  Peptide "mapping" was carried out exactly as described previously except  that 
carboxymethylation was carried out before sodium dodecyl sulphate (SDS)-polyacrylamide gel 
electrophoresis (17). Briefly, iodinated polypeptides were purified by immunoprecipitation and 
SDS-polyacrylamide gel electrophoresis. The labeled species were separately extracted from the 
gels and digested with trypsin. Tryptic peptides were then analyzed on 20 X 20-cm thin-layer 
cellulose  plates by electrophoresis in the first  dimension followed by chromatography in the 
second dimension. 
Results 
Mac- 1 is a differentiation antigen found on macrophages defined by the monoclonal 
antibody M1/70  (12,  13).  This  monoclonal antibody precipitates  two labeled  poly- 
peptides  (apparent  Mr of 190,000 and  105,000, respectively)  from lysates of surface- 
iodinated macrophages (13). In the course of characterizing the surface glycoproteins 
of murine  hematopoietic cells, we obtained  two other monoclonal antibodies,  desig- 
nated  I21/7 and C71/16,  that  appeared  to precipitate  similar polypeptides  to those 
detected with M1/70  monoclonal antibody.  In contrast  to M1/70  monoclonal anti- 
body,  however,  both  these  antibodies  reacted  with  virtually  all  thymocytes  and  a 
substantial  fraction  of spleen  and  bone  marrow  cells,  as judged  by  fluorescence- 
activated  cell  analysis.  Moreover,  these  two antibodies  reacted  with  many different 
murine  hematopoietic  tumor  cell  lines,  including  T  lymphomas,  Abelson-virus-in- 
duced  B  cell  lines,  and  Friend  virus-induced  erythroleukemias.  Antibody-blocking 
experiments  showed  that  although  all  three  antibodies  precipitate  similar  polypep- 
tides,  each  antibody reacted  with  distinct  antigenic  determinants.  This was  further 
documented in a  striking fashion by the reactivity of the antibodies with BW5147, a IAN  S.  TROWBRIDGE  AND  M.  BISHR  OMARY  1519 
murine T  lymphoma cell line (14),  and M1, an inducible macrophage cell line (15, 
16). As shown in Fig.  1, Mac-1  was expressed on the macrophage cell line but  not 
BW5147 cells, as might be predicted from its known distribution on normal leukocytes 
(12,  13). In contrast, I21/7  antibody reacted with BW5147  cells but  not with M1 
cells. C71/16 monoclonal antibody, on the other hand, reacted with both cell lines. 
Despite the disparate reactivity of the monoclonal antibodies with BW5147  cells 
and M1  cells,  a comparison of the labeled polypeptides precipitated from lysates of 
FIG.  1.  Quantitative binding of monoclonal antibodies to  BW5147 and  MI  cells.  Fluorescence- 
activated  cell  analysis was  carried  out  as  described  in  Materials  and  Methods  using saturating 
amounts of antibodies. M1 cells were grown in the presence of 5  ×  10  -n M  dexamethasone for 3 d 
before analysis to induce differentiation along the macrophage pathway. The results are presented 
as two-dimensional displays using a three-decade logarithmic amplifier for fluorescence. The mean 
relative  fluorescence was determined by  relating the peak  fluorescent channel  for each cell  type 
stained with  various reagents to  the absolute fluorescence of standard beads analyzed  under the 
same conditions. The staining of BW5147 cells with anti-T200 monoclonal antibody was set at  1.0. 
* Indicates relative binding of at least four times background values. 
Monoclonal antibody 
Relative binding to 
BW5147  M1 
None  0.02  0.02 
T200  1.0"  0.8* 
I21/7  0.3*  0.02 
C71/16  0.2*  0.08* 
Mac- 1  0.02  0.09* 1520  MAC-1 GLYCOPROTEINS 
Fic.  2.  SDS-polyacrylamide  gel analysis  of the labeled polypeptides  precipitated  by M1/70, C71/ 
16, and 121/7 monoclonal  antibodies from lysates  of '25I-labeled BW5147 cells and dexamethasone- 
induced M I ceils. 
the iodinated cells confirmed that similar species were precipitated from BW5147 cells 
by I21/7 and C71/16 antibodies  (Fig.  2a, b) and by C71/16 and M1/70 antibodies 
from  M1  cells  (Fig.  2c,  d).  In  each  case,  two  polypeptides,  both  of which  were 
glycosylated as judged by metabolic labeling with [2-3H]mannose, were detected. The 
apparent molecular weights of the smaller species from each cell line were identical 
(Mr =  95,000), whereas the larger polypeptide from BW5147 cells and precipitated 
by  both  I21/7  and  C71/16  antibodies  migrated  with  a  slightly  higher  apparent 
molecular  weight  (Mr  =  170,000)  than  the  species  obtained  from  M1  cells  by 
precipitation with M1/70 and C71/16 antibodies. 
To further investigate the structural relationship between the various glycosylated 
polypeptides precipitated from the two cell lines by the different monoclonal anti- 
bodies, each radioiodinated species was isolated, tryptic peptides prepared, and then 
each  digest  analyzed  on  thin-layer  cellulose  plates  by  electrophoresis  in  the  first 
dimension  and  chromatography in  the second  dimension.  As  shown  in  Fig.  3,  the 
labeled  tryptic peptides  of the  lower molecular weight  polypeptide from  M1  and 
BW5147  cells precipitated by each antibody were indistinguishable  (Fig.  3e-h).  In 
contrast,  the  labeled  tryptic peptides  of the  higher  molecular weight  polypeptides 
from  M1  and  BW5147  cells appeared  to  be  quite  different  by.~the same  criterion. 
C71/16 monoclonal antibody, which reacts with both cell lines, therefore precipitates 
a different high molecular weight polypeptide from each cell type (Fig. 3 b, c). These 
conclusions were confirmed by analysis of the appropriate mixtures of tryptic peptides 
by the same methods (datanot shown). 
Discussion 
The  results  reported  in  this  communication  show  that  Mac-1  is  an  antigenic 
determinant expressed on a  glycoprotein complex that is a  member of a structurally 
and antigenically related family of molecules found on hematopoietic cell types other 
than mononuclear phagocytes. This is most clearly illustrated by the results obtained 
with  monoclonal  antibody  C71/16,  which  reacts  with  an  antigenic  determinant IAN S. TROWBRIDGE  AND  M.  BISHR  OMARY  1521 
FIG. 3.  Comparison of the labeled tryptic peptides from the polypeptides precipitated by M1/70, 
C71/16,  and  I21/7  monoclonal  antibodies  from lysates of l~SI-labeled M1  and  BW5147 cells. 
Polypeptides were immunopreclpitated and separated by SDS-polyacrylamide gel electrophoresis 
(see Fig. 2).  The  170,000-mol wt  polypeptides  (higher  Mr polypeptide)  and  the 95,000-mol wt 
polypeptides (lower Mr polypeptide) were then extracted from the gel and separately processed for 
peptide mapping as described in Materials and Methods. Approximately 10,000 cpm of the high 
molecular weight protein digests and 6,000 cpm of the low molecular weight protein  digests were 
loaded onto the cellulose plates and exposure of the autoradiographs was for 3 d. 
common to the forms of the glycoprotein found on the macrophage cell line M 1 and 
the T  lymphoma cell line BW5147. 
Whereas a  plausible interpretation of the serological and structural data presented 
is  that  C71/16  monoclonal  antibody  reacts  with  an  antigenic  determinant  on  the 
lower molecular weight  polypeptide common  to the glycoprotein complexes of both 
M1  and BW5147 cells, and that I21/7 and M 1/70 monoclonal antibodies react with 
the higher molecular weight polypeptides that are dissimilar, further work is required. 
For example, there is no definitive evidence that  the high and low molecular weight 
polypeptides are physically associated, and  it cannot  be excluded  that  each  mono- 
clonal antibody reacts with both despite the data from peptide mapping. A  separate 
question is whether the antigenic differences detected reflect either post-translational 1522  MAC-I GLYCOPROTEINS 
modifications  of a  single  gene  product  such  as  glycosylation or  an  expression  of 
distinct but related genes in the different hematopoietic cell types. 
The difference in structure between the glycoproteins recognized by I21/7 and M 1/ 
70 monoclonal antibodies may be of functional significance since I21/7 monoclonal 
antibody  binds  to  cytotoxic T  cell  lines  and  blocks  their  cytolytic  activity  (M. 
Sarmiento  and  I.  S.  Trowbridge,  manuscript  in  preparation),  An  antibody  with 
similar  properties has recently been described by Springer and  his colleagues  (22). 
Since it is known that M1/70 monoclonal antibody recognizes an antigenic determi- 
nant on human myeloid cells (23), this also raises the possibility that a similar family 
of glycoproteins defined in  the  mouse by M1/70,  I21/7,  and  C71/16  monoclonal 
antibodies exists in man. 
It is evident that the results reported in this communication raise many interesting 
questions concerning the structure and function of these related cell surface glycopro- 
teins shared by macrophages and T  cells.  It has been reported that during induction 
of M 1 cells there is an increase in a prominent 180,000 surface glycoprotein found on 
normal  macrophages  (24),  and  some  evidence has  been  presented  suggesting  this 
molecule may play a role in cell adhesion (16). The glycoprotein complex defined by 
Mac-1 and C71/16 monoclonal antibodies also increases in expression during induc- 
tion of M 1 cells with dexamethasone (M. B. Omary and I. S. Trowbridge, unpublished 
results)  and  thus  the  high  molecular weight  polypeptide of this  complex  may be 
identical  to  this  previously  described  glycoprotein.  It  is  possible,  therefore,  that 
variants of these glycoproteins on other hematopoietic cell types are also involved in 
cell-cell or cell-substratum interactions. The major point that is clearly documented, 
however, is that the structural and antigenic complexity of this family of cell surface 
glycoproteins accounts for the limited cellular distribution of the Mac-1 differentiation 
antigen.  This  situation  closely  resembles  that  previously  observed  for  the  T200 
glycoprotein family (4-11) and emphasizes both the power of the monoclonal antibody 
technique in the analysis of cell surfaces, and the potential complications that may be 
encountered in such studies. From the viewpoint of the possible involvement of cell 
surface structures in cellular functions, it is of considerable importance to establish 
whether  monoclonal  antibodies  that  react  with  specific  cell  types  define  surface 
antigenic determinants or molecules unique to particular differentiated cells. 
Summary 
Monoclonal antibodies have been obtained that react with the murine leukocyte 
surface glycoproteins bearing the macrophage differentiation antigen Mac-1.  Struc- 
tural  and  antigenic  analysis  shows  that  related  glyeoproteins are  found  on  other 
murine hematopoietic cell types. The data not only illustrate the complexity of cell 
surface structures that can be detected by means of monoclonal antibodies, but also 
raise questions as to the functional significance of this family of molecules within the 
hematopoietic system. 
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